Domov › Neuroblastom › Florida
Klinické štúdie Neuroblastom v štáte Florida
9 štúdií pre Neuroblastom hľadá účastníkov v zariadeniach v štáte Florida.
Mestá v štáte Florida
Oficiálny text štúdie (anglicky)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Broward Health Medical Center, Fort Lauderdale
- Golisano Children's Hospital of Southwest Florida, Fort Myers
- UF Health Cancer Institute - Gainesville, Gainesville
- a 9 ďalších
Prebieha náborFáza 3
Do veku 30 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06172296Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Johns Hopkins All Children's Hospital ( Site 1025), St. Petersburg
Prebieha náborFáza 1/2
6 Months – 25 Years · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT06395103Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Nicklaus Children's Miami, Miami
- Arnold Palmer Hospital for Children, Orlando
- St. Joseph's Children's Hospital, Tampa
Prebieha náborFáza 2
Do veku 22 · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT02559778Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- University of Florida, Gainesville
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
- a 1 ďalších
Prebieha náborFáza 1/2
Do veku 26 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06465199Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- University of Florida, Gainesville
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
- a 2 ďalších
Prebieha náborFáza 1/2
Do veku 30 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06541262Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
Prebieha náborFáza 2
Vek 1 až 21 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06540963Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Golisano Children's Hospital of Southwest Florida, Fort Myers
- UF Health Cancer Institute - Gainesville, Gainesville
- Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
- a 7 ďalších
Prebieha náborFáza 3
365 Days – 30 Years · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT03126916Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- University of Florida, Gainesville
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
Prebieha náborFáza 2
12 Months – 21 Years · Všetky pohlavia · Aktualizované 12. 8. 2026 · NCT05489887Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
- University of Florida, Gainesville
Prebieha náborFáza 1/2
6 Months – 25 Years · Všetky pohlavia · Aktualizované 30. 6. 2026 · NCT06625190Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.